Company / AR per Share
Fulgent Genetics, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$2.75
FY2025
5-year range
$1.74 / $4.93
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
#72 of 136
Health Care
What the data says
At $2.75, Fulgent Genetics, Inc.'s ar per share ranks #72 of 136 in the Health Care sector. AR per Share has fluctuated over the past 10 years, ranging from $0.23 in FY2017 to $8.56 in FY2020.
Based on SEC 10-K filings.
2.75 in FY2025 with a 5-year CAGR of -20.3%.
Improved from $1.74 to $2.75 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +16.3%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Sector benchmark
#72 of 136 in Health CareTop 53% of 136This company $2.75 Sector average $12.05
▼
-77.2% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 18.1% year-over-year.
- Ranks #72 out of 136 companies in the Health Care sector.
- Peak ar per share was recorded in FY2020.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.75 | +18.1% |
| FY2024 | $2.33 | +34.0% |
| FY2023 | $1.74 | -0.7% |
| FY2022 | $1.75 | -64.5% |
| FY2021 | $4.93 | -42.4% |
| FY2020 | $8.56 | +2272.5% |
| FY2019 | $0.36 | +8.2% |
| FY2018 | $0.33 | +47.1% |
| FY2017 | $0.23 | -8.2% |
| FY2016 | $0.25 | +38.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026